Hepatitis C Medicines

A Contract Award Notice
by NHS NATIONAL SERVICES SCOTLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£4M-£4M
Sector
HEALTH
Published
07 Feb 2022
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 5 suppliers

1 buyer

3 suppliers

Description

The framework agreement is awarded for the supply of medicines used to treat Hepatitis C to NHS Scotland.

Lot Division

1 Treatment Cost per Medicine

This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.

2 Treatment Spend Cap

This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.

Award Detail

1 Abbvie (Maidenhead)
  • Treatment Cost per Medicine
  • Reference: 003365-2022-1
  • Value: £3,500,000 [share]
  • Awarded to group of suppliers.
2 Gilead Sciences (London)
  • Treatment Cost per Medicine
  • Reference: 003365-2022-1
  • Value: £3,500,000 [share]
  • Awarded to group of suppliers.
3 Merck Sharp & Dohme (Hoddesdon)
  • Treatment Cost per Medicine
  • Reference: 003365-2022-1
  • Value: £3,500,000 [share]
  • Awarded to group of suppliers.
4 Abbvie (Maidenhead)
  • Treatment Spend Cap
  • Reference: 003365-2022-2
  • Value: £4,000,000 [share]
  • Awarded to group of suppliers.
5 Gilead Sciences (London)
  • Treatment Spend Cap
  • Reference: 003365-2022-2
  • Value: £4,000,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and both Lots covers the twelve (12) month modification period of the framework agreement. (SC Ref:682305)

Reference

Domains